Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice.

Bilel S, Tirri M, Arfè R, Ossato A, Trapella C, Serpelloni G, Neri M, Fattore L, Marti M.

Neurotoxicology. 2019 Oct 11;76:17-32. doi: 10.1016/j.neuro.2019.10.002. [Epub ahead of print]

PMID:
31610187
2.

Corrigendum to < Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brain>.

M D, C B, M A, Giuda D D, F C, L F, G A.

Alcohol. 2019 Oct 10. pii: S0741-8329(19)30246-0. doi: 10.1016/j.alcohol.2019.10.003. [Epub ahead of print] No abstract available.

PMID:
31606545
3.

ErbB3 Phosphorylation as Central Event in Adaptive Resistance to Targeted Therapy in Metastatic Melanoma: Early Detection in CTCs during Therapy and Insights into Regulation by Autocrine Neuregulin.

Ruggiero CF, Malpicci D, Fattore L, Madonna G, Vanella V, Mallardo D, Liguoro D, Salvati V, Capone M, Bedogni B, Ascierto PA, Mancini R, Ciliberto G.

Cancers (Basel). 2019 Sep 25;11(10). pii: E1425. doi: 10.3390/cancers11101425.

4.

Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Cocaine Use Disorder: A Pilot Study.

Sanna A, Fattore L, Badas P, Corona G, Cocco V, Diana M.

Front Neurosci. 2019 Jul 25;13:765. doi: 10.3389/fnins.2019.00765. eCollection 2019.

5.

CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.

Bruschini S, di Martino S, Pisanu ME, Fattore L, De Vitis C, Laquintana V, Buglioni S, Tabbì E, Cerri A, Visca P, Alessandrini G, Facciolo F, Napoli C, Trombetta M, Santoro A, Crescenzi A, Ciliberto G, Mancini R.

J Cell Physiol. 2019 Aug 9. doi: 10.1002/jcp.29121. [Epub ahead of print]

PMID:
31397494
6.

Editorial: Novel Psychoactive Drugs.

Fattore L, Weinstein AM.

Front Psychiatry. 2019 Mar 11;10:119. doi: 10.3389/fpsyt.2019.00119. eCollection 2019. No abstract available.

PMID:
30914980
Free PMC Article
7.

Clinical outcomes, pharmacological treatment, and quality of life of patients with stable coronary artery diseases managed by cardiologists: 1-year results of the START study.

De Luca L, Temporelli PL, Riccio C, Gonzini L, Marinacci L, Tartaglione SN, Costa P, Scherillo M, Senni M, Colivicchi F, Gulizia MM; START Investigators .

Eur Heart J Qual Care Clin Outcomes. 2019 Oct 1;5(4):334-342. doi: 10.1093/ehjqcco/qcz002.

PMID:
30649303
8.

c-Src Recruitment is Involved in c-MET-Mediated Malignant Behaviour of NT2D1 Non-Seminoma Cells.

Leonetti E, Gesualdi L, Scheri KC, Dinicola S, Fattore L, Masiello MG, Cucina A, Mancini R, Bizzarri M, Ricci G, Catizone A.

Int J Mol Sci. 2019 Jan 14;20(2). pii: E320. doi: 10.3390/ijms20020320.

9.

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

Sawhney JP, Kothiwale VA, Bisne V, Durgaprasad R, Jadhav P, Chopda M, Vanajakshamma V, Meena R, Vijayaraghavan G, Chawla K, Allu J, Pieper KS, John Camm A, Kakkar AK; GARFIELD-AF Investigators.

Indian Heart J. 2018 Nov - Dec;70(6):828-835. doi: 10.1016/j.ihj.2018.09.001. Epub 2018 Sep 12.

10.

Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma.

Pisanu ME, Maugeri-Saccà M, Fattore L, Bruschini S, De Vitis C, Tabbì E, Bellei B, Migliano E, Kovacs D, Camera E, Picardo M, Jakopin Z, Cippitelli C, Bartolazzi A, Raffa S, Torrisi MR, Fulciniti F, Ascierto PA, Ciliberto G, Mancini R.

J Exp Clin Cancer Res. 2018 Dec 17;37(1):318. doi: 10.1186/s13046-018-0989-7.

11.

The potential of BRAF-associated non-coding RNA as a therapeutic target in melanoma.

Fattore L, Mancini R, Ascierto PA, Ciliberto G.

Expert Opin Ther Targets. 2019 Jan;23(1):53-68. doi: 10.1080/14728222.2019.1554057. Epub 2018 Dec 9. Review.

PMID:
30507327
12.

Mediterranean Neuroscience Methods 2017.

Fattore L, Landry M, Giovanni GD.

J Neurosci Methods. 2018 Dec 1;310:1-2. doi: 10.1016/j.jneumeth.2018.11.002. No abstract available.

PMID:
30466665
13.

Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats.

Ruda-Kucerova J, Zanda MT, Amchova P, Fratta W, Fattore L.

Front Behav Neurosci. 2018 Oct 30;12:255. doi: 10.3389/fnbeh.2018.00255. eCollection 2018.

14.

Repetitive transcranial magnetic stimulation: Re-wiring the alcoholic human brain.

Diana M, Bolloni C, Antonelli M, Di Giuda D, Cocciolillo F, Fattore L, Addolorato G.

Alcohol. 2019 Feb;74:113-124. doi: 10.1016/j.alcohol.2018.05.011. Epub 2018 Jun 2. Review.

PMID:
30420113
15.

The Modulating Role of Sex and Anabolic-Androgenic Steroid Hormones in Cannabinoid Sensitivity.

Struik D, Sanna F, Fattore L.

Front Behav Neurosci. 2018 Oct 26;12:249. doi: 10.3389/fnbeh.2018.00249. eCollection 2018. Review.

16.

The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats.

Costa G, Serra M, Pintori N, Casu MA, Zanda MT, Murtas D, De Luca MA, Simola N, Fattore L.

Neuropharmacology. 2019 Jan;144:219-232. doi: 10.1016/j.neuropharm.2018.10.031. Epub 2018 Oct 23.

PMID:
30366005
17.

Reprogramming miRNAs global expression orchestrates development of drug resistance in BRAF mutated melanoma.

Fattore L, Ruggiero CF, Pisanu ME, Liguoro D, Cerri A, Costantini S, Capone F, Acunzo M, Romano G, Nigita G, Mallardo D, Ragone C, Carriero MV, Budillon A, Botti G, Ascierto PA, Mancini R, Ciliberto G.

Cell Death Differ. 2019 Jul;26(7):1267-1282. doi: 10.1038/s41418-018-0205-5. Epub 2018 Sep 25.

18.

Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?

De Luca MA, Fattore L.

Clin Ther. 2018 Sep;40(9):1457-1466. doi: 10.1016/j.clinthera.2018.08.002. Epub 2018 Sep 1.

PMID:
30180974
19.

Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice.

Ossato A, Bilel S, Gregori A, Talarico A, Trapella C, Gaudio RM, De-Giorgio F, Tagliaro F, Neri M, Fattore L, Marti M.

Neuropharmacology. 2018 Oct;141:167-180. doi: 10.1016/j.neuropharm.2018.08.017. Epub 2018 Aug 27.

PMID:
30165078
20.

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps.

Miliano C, Margiani G, Fattore L, De Luca MA.

Brain Sci. 2018 Jun 29;8(7). pii: E123. doi: 10.3390/brainsci8070123. Review.

21.

Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats.

Rosas M, Porru S, Giugliano V, Antinori S, Scheggi S, Fadda P, Fratta W, Acquas E, Fattore L.

Behav Pharmacol. 2018 Sep;29(6):473-481. doi: 10.1097/FBP.0000000000000395.

PMID:
29595540
22.

Old and new synthetic cannabinoids: lessons from animal models.

Zanda MT, Fattore L.

Drug Metab Rev. 2018 Feb;50(1):54-64. doi: 10.1080/03602532.2018.1430824. Epub 2018 Jan 29. Review.

PMID:
29376443
23.

Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.

Fattore L, Piva A, Zanda MT, Fumagalli G, Chiamulera C.

Psychopharmacology (Berl). 2018 Feb;235(2):433-445. doi: 10.1007/s00213-017-4793-4. Epub 2017 Nov 25. Review.

PMID:
29178010
24.

Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Weinstein AM, Rosca P, Fattore L, London ED.

Front Psychiatry. 2017 Aug 23;8:156. doi: 10.3389/fpsyt.2017.00156. eCollection 2017. Review.

25.

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease.

HPS3/TIMI55–REVEAL Collaborative Group, Bowman L, Hopewell JC, Chen F, Wallendszus K, Stevens W, Collins R, Wiviott SD, Cannon CP, Braunwald E, Sammons E, Landray MJ.

N Engl J Med. 2017 Sep 28;377(13):1217-1227. doi: 10.1056/NEJMoa1706444. Epub 2017 Aug 28.

26.

Methoxetamine affects brain processing involved in emotional response in rats.

Zanda MT, Fadda P, Antinori S, Di Chio M, Fratta W, Chiamulera C, Fattore L.

Br J Pharmacol. 2017 Oct;174(19):3333-3345. doi: 10.1111/bph.13952. Epub 2017 Aug 19.

27.

MicroRNA-driven deregulation of cytokine expression helps development of drug resistance in metastatic melanoma.

Fattore L, Sacconi A, Mancini R, Ciliberto G.

Cytokine Growth Factor Rev. 2017 Aug;36:39-48. doi: 10.1016/j.cytogfr.2017.05.003. Epub 2017 May 17. Review.

PMID:
28551321
28.

Selective targeting of point-mutated KRAS through artificial microRNAs.

Acunzo M, Romano G, Nigita G, Veneziano D, Fattore L, Laganà A, Zanesi N, Fadda P, Fassan M, Rizzotto L, Kladney R, Coppola V, Croce CM.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4203-E4212. doi: 10.1073/pnas.1620562114. Epub 2017 May 8.

29.

Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex.

Antinori S, Fattore L, Saba P, Fratta W, Gessa GL, Devoto P.

Addict Biol. 2018 Mar;23(2):556-568. doi: 10.1111/adb.12509. Epub 2017 Apr 21.

PMID:
28429835
30.

MicroRNAs in melanoma development and resistance to target therapy.

Fattore L, Costantini S, Malpicci D, Ruggiero CF, Ascierto PA, Croce CM, Mancini R, Ciliberto G.

Oncotarget. 2017 Mar 28;8(13):22262-22278. doi: 10.18632/oncotarget.14763. Review.

31.

The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function.

Struik D, Fadda P, Zara T, Zamberletti E, Rubino T, Parolaro D, Fratta W, Fattore L.

Pharmacol Res. 2017 Jan;115:209-217. doi: 10.1016/j.phrs.2016.11.031. Epub 2016 Nov 24.

PMID:
27890818
32.

The novel cannabinoid antagonist SM-11 reduces hedonic aspect of food intake through a dopamine-dependent mechanism.

Fois GR, Fattore L, Murineddu G, Salis A, Pintore G, Asproni B, Pinna GA, Diana M.

Pharmacol Res. 2016 Nov;113(Pt A):108-115. doi: 10.1016/j.phrs.2016.08.012. Epub 2016 Aug 10.

PMID:
27521837
33.

Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study.

De Luca L, Leonardi S, Smecca IM, Formigli D, Lucci D, Gonzini L, Tuccillo B, Olivari Z, Gulizia MM, Bovenzi FM, De Servi S; EYESHOT Investigators.

Eur Heart J Cardiovasc Pharmacother. 2015 Jul;1(3):168-78. doi: 10.1093/ehjcvp/pvv006. Epub 2015 Feb 24.

PMID:
27533991
34.

miR-579-3p controls melanoma progression and resistance to target therapy.

Fattore L, Mancini R, Acunzo M, Romano G, Laganà A, Pisanu ME, Malpicci D, Madonna G, Mallardo D, Capone M, Fulciniti F, Mazzucchelli L, Botti G, Croce CM, Ascierto PA, Ciliberto G.

Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):E5005-13. doi: 10.1073/pnas.1607753113. Epub 2016 Aug 8.

35.

Emotional profile of female rats showing binge eating behavior.

Satta V, Scherma M, Giunti E, Collu R, Fattore L, Fratta W, Fadda P.

Physiol Behav. 2016 Sep 1;163:136-143. doi: 10.1016/j.physbeh.2016.05.013. Epub 2016 May 11. No abstract available.

PMID:
27180132
36.

Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.

Zanda MT, Fadda P, Chiamulera C, Fratta W, Fattore L.

Behav Pharmacol. 2016 Sep;27(6):489-96. doi: 10.1097/FBP.0000000000000241. Review.

PMID:
27128862
37.

Drug addiction: An affective-cognitive disorder in need of a cure.

Fattore L, Diana M.

Neurosci Biobehav Rev. 2016 Jun;65:341-61. doi: 10.1016/j.neubiorev.2016.04.006. Epub 2016 Apr 16. Review.

PMID:
27095547
38.

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists.

Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators.

Br J Haematol. 2016 Aug;174(4):610-23. doi: 10.1111/bjh.14084. Epub 2016 Apr 12.

PMID:
27071942
39.

The ketamine-like compound methoxetamine substitutes for ketamine in the self-administration paradigm and enhances mesolimbic dopaminergic transmission.

Mutti A, Aroni S, Fadda P, Padovani L, Mancini L, Collu R, Muntoni AL, Fattore L, Chiamulera C.

Psychopharmacology (Berl). 2016 Jun;233(12):2241-51. doi: 10.1007/s00213-016-4275-0. Epub 2016 Mar 28.

PMID:
27020786
40.

Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.

Fattore L.

Biol Psychiatry. 2016 Apr 1;79(7):539-48. doi: 10.1016/j.biopsych.2016.02.001. Epub 2016 Feb 4. Review.

PMID:
26970364
41.

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.

Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM; ROCKET AF Steering Committee & Investigators; ROCKET AF Steering Committee Investigators.

J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.

42.

Editorial: Exploring Gender and Sex Differences in Behavioral Dyscontrol: From Drug Addiction to Impulse Control Disorders.

Fattore L, Melis M.

Front Psychiatry. 2016 Feb 22;7:19. doi: 10.3389/fpsyt.2016.00019. eCollection 2016. No abstract available.

43.

Sex differences in impulsive and compulsive behaviors: a focus on drug addiction.

Fattore L, Melis M.

Addict Biol. 2016 Sep;21(5):1043-51. doi: 10.1111/adb.12381. Epub 2016 Mar 3. Review.

PMID:
26935237
44.

The ketamine analogue methoxetamine generalizes to ketamine discriminative stimulus in rats.

Chiamulera C, Armani F, Mutti A, Fattore L.

Behav Pharmacol. 2016 Apr;27(2-3 Spec Issue):204-10. doi: 10.1097/FBP.0000000000000221.

PMID:
26866970
45.

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M.

Psychopharmacology (Berl). 2016 May;233(10):1765-77. doi: 10.1007/s00213-015-4196-3. Epub 2016 Jan 4. Review.

PMID:
26728894
46.

Temporal bone meningioma involving the middle ear: A case report.

Ricciardiello F, Fattore L, Liguori ME, Oliva F, Luce A, Abate T, Caraglia M, Pianese A, Raucci AF.

Oncol Lett. 2015 Oct;10(4):2249-2252. Epub 2015 Jul 20.

47.

Reward processing and drug addiction: does sex matter?

Fattore L.

Front Neurosci. 2015 Sep 29;9:329. doi: 10.3389/fnins.2015.00329. eCollection 2015. No abstract available.

48.

Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P.

Neuropsychopharmacology. 2016 Apr;41(5):1416-26. doi: 10.1038/npp.2015.295. Epub 2015 Sep 21.

49.

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma.

Fattore L, Malpicci D, Marra E, Belleudi F, Noto A, De Vitis C, Pisanu ME, Coluccia P, Camerlingo R, Roscilli G, Ribas A, Di Napoli A, Torrisi MR, Aurisicchio L, Ascierto PA, Mancini R, Ciliberto G.

Oncotarget. 2015 Sep 22;6(28):24823-41. doi: 10.18632/oncotarget.4485.

50.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

Supplemental Content

Loading ...
Support Center